Back to results
US 5,928,947 AGranted
Mammalian multipotent neural stem cells
AssigneeCalifornia Institute of Technology
InventorsDavid J. Anderson, Derek L. Stemple
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeCalifornia Institute of Technology
InventorsDavid J. Anderson, Derek L. Stemple
Estimating the term…
The invention includes mammalian multipotent neural stem cells and their progeny and methods for the isolation and clonal propagation of such cells. At the clonal level the stem cells are capable of self regeneration and asymmetrical division. Lineage restriction is demonstrated within developing clones which are sensitive to the local environment. The invention also includes such cells which are transfected with foreign nucleic acid, e.g., to produce an immortalized neural stem cell. The invention further includes transplantation assays which allow for the identification of mammalian multipotent neural stem cells from various tissues and methods for transplanting mammalian neural stem cells and/or neural or glial progenitors into mammals. A novel method for detecting antibodies to neural cell surface markers is disclosed as well as a monoclonal antibody to mouse LNGFR.
A method for making a genetically engineered cell selected from the group consisting of smooth muscle cells, peripheral nervous system (PNS) neuronal cells, or PNS glial cells, comprising differentiating a genetically engineered neural crest stem cell to one of smooth muscle cells, PNS neuronal cells, or PNS glial cells, wherein said genetically engineered neural crest stem cells are a clonal population made by in vitro modification and are capable of self-renewal in a feeder cell-independent culture medium, express low-affinity nerve growth factor receptor (LNGFR) and nestin, but do not express neuronal or glial lineage markers including glial fibrillary acidic protein (GFAP), wherein at least one of said stem cells is capable of differentiation to a peripheral nervous system (PNS) neuronal cell that does not express LNGFR or nestin but does express neurofilament-160, and wherein at least one of said stem cells is capable of differentiation to a PNS glial cell that expresses LNGFR, nestin and GFAP.
A method comprising introducing one or more neural crest stem cells into a host animal wherein said neural crest stem cells are capable of self-renewal in a feeder cell-independent culture medium, express low-affinity nerve growth factor receptor (LNGFR) and nestin, but do not express neuronal or glial lineage markers including glial fibrillary acidic protein (GFAP), wherein at least one of said stem cells is capable of differentiation to a peripheral nervous system (PNS) neuronal cell that does not express LNGFR or nestin but does express neurofilament-160, and wherein at least one of said stem cells is capable of differentiation to a PNS glial cell that expresses LNGFR, nestin and GFAP.
Dependencies are inferred from the claim text.